Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales264395401397497574
Operating income (EBITDA)-25,210456,015,591,6151
Operating profit (EBIT)-33,285,545,19,8981,0151
Pre-Tax Profit (EBT)-32,985,9-96,4---
Net income-32,985,9-18,1-1332,5915,6
EPS ( $)-0,691,74-0,37-2,58-0,390,27
Dividend per Share ( $)------
Yield------
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Finances - Leverage
Auxilium Pharmaceuticals,  : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt--246469447345
Finance154157----
Operating income (EBITDA)-25,210456,015,591,6151
Leverage
(Debt/EBITDA)
--4,39x30,3x4,88x2,29x
Capital Expenditure6,648,7610,49,5911,211,8
Book Value Per Share (BVPS)1,75 $4,06 $5,07 $3,73 $3,72 $4,64 $
Cash Flow per Share0,64 $-0,05 $-0,24 $1,71 $3,01 $3,93 $
Announcement Date02/23/2012
12:00pm
02/26/2013
12:00pm
02/28/2014
11:30am
---
Balance Sheet Analysis
Auxilium Pharmaceuticals,  : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 1 006 M$ -
Entreprise Value (EV) 1 475 M$ 1 453 M$
Valuation 2014e 2015e
PER (Price / EPS)
Capitalization / Revenue 2,53x 2,03x
EV / Revenue 3,71x 2,93x
EV / EBITDA 95,3x 15,9x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 2,49% 16,3%
operating Leverage (Delta EBIT / Delta Sales) # 28,8x
Net Margin (Net Profit / Revenue) -33,4% 0,52%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -3,06% 47,2%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   2,41% 2,25%
Cash Flow / Sales (Taux d'autofinancement) 21,6% 30,5%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 30,3x 4,88x
Price Earning Ratio
Auxilium Pharmaceuticals,  : Price Earning Ratio
EPS & Dividend
Auxilium Pharmaceuticals,  : EPS Dividend
Dynamic quotes  
ON
| OFF